Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02065817 · ClinicalTrials.gov registry record · NA
Dose of Labeled Cholesterol for Kinetics: A Pilot Study
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02065817: Completed NA study, sponsored by Mayo Clinic.
NCT02065817 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02065817, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics.
Primary Outcome
13C3 cholesterol, which is labeled with a stable isotope, will be administered orally. Blood samples will be taken every 4-6 hours for 72 hours for the measurement of stable isotopic enrichment in cholesterol using gas chromatography-mass spectrometry. The study has a dual purpose: to determine the optimum oral dose of isotope, and to determine the time of peak enrichment in plasma cholesterol.
Interventions
- OTHER stable isotope of cholesterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02065817 record still lists
NCT02065817 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which stable isotope of cholesterol is the first listed.
NCT02065817 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02065817 about?
NCT02065817 is a clinical study titled "Dose of Labeled Cholesterol for Kinetics: A Pilot Study". This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics.
What is the current status of trial NCT02065817?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-02. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02065817?
The interventions under investigation include: stable isotope of cholesterol (OTHER).
Who is sponsoring clinical trial NCT02065817?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02065817's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia